Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects

• Main Authors: James Brown (Author), Zhe Li (Author), Xi Wang (Author), Yu Jeong Kim (Author), Yu-Chen Wang (Author), Yanning Zuo (Author), Weizhe Hong (Author), Pin Wang (Author), Bo Li (Author), Lili Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

MAOIs, a well-established class of antidepressant that operate through the inhibition of monoamine oxidase to increase available serotonin, have recently been identified as a surprisingly effective candidate for the circumvention of tumor-induced immune suppression due to their abilities to enhance...